Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Sale of 9,989 TEVA shares, $321.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 9,989 | $321.5K |
| Jun 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 16,195 | n/a |
| Mar 9, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 17,295 | n/a |
| Mar 6, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 33,424 | n/a |
| Jun 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 16,195 | n/a |
| Mar 7, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 69,182 | n/a |
| Jun 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 64,782 | n/a |